Who We Are

Genvax Technologies is a startup animal vaccine company located in Ames, Iowa. We have a dynamic team of experienced scientists and entrepreneurs poised to develop next generation mRNA + nanoparticle vaccines. This isn’t the first go-around for co-founders Joel Harris and Dr. Hank Harris, who successfully created, grew and sold Harrisvaccines to Merck Animal Health in 2015.

We are focused on developing novel vaccines for the prevention and treatment of animal diseases. We cultivate new ideas to make our world a better place and strive to create a long-lasting impact on animal health world-wide.

We believe in rapidly responding to the world around us. We are Genvax and we are committed to making the world a better place.

Our Mission & Vision

Mission: Genvax Technologies accelerates breakthrough solutions to the animal health industry. We commercialize the tools for livestock producers and veterinarians that no one else can.

Vision: We believe in rapidly responding to the world around us. We cultivate new ideas to develop novel solutions and create a long-lasting impact on animal health world-wide.

Our Team

Joel Harris


Hank Harris, DVM PhD


Hannah Hill


Jake Seibert, PhD

Molecular Biology Lead

Donna Gruis

Coordinator of Regulatory Affairs

Dennis O'Neill

Molecular Biology Lead

Open Positions

Looking to join our team?

We are looking for those who aren’t afraid to wear many hats at Genvax and will accept challenges to grow professionally along the way. If you are looking for progressive technology coupled with modern culture and aren’t afraid of a challenge, this may be the place for you. If you are interested in joining our team, we are currently looking for individuals for the following positions:

Interested in one of these positions and want to learn more? Email us at info@genvax.com

For a full list of open positions, please visit us on LinkedIn.

Our Technology

Highly Scalable

  • Lower Manufacturing Cost
  • No bottlenecking manufacturing steps

Scientific Advantages

This website only uses cookies when you subscribe as discussed in our Cookie Policy Here. I Accept All Cookies